Clough Capital Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Clough Capital Partners’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-47,900	Closed	-$5.51M	–	237
2014 Q4	$5.51M	Buy	47,900 +24,220	+102%	+$2.93M	0.2%	120
2014 Q3	$3.7M	Sell	23,680 -109,920	-82%	-$15.9M	0.14%	126
2014 Q2	$16.5M	Buy	133,600 +39,800	+42%	+$4.4M	0.52%	76
2014 Q1	$9.72M	Buy	93,800 +300	+0.3%	+$30.7K	0.3%	105
2013 Q4	$8.41M	Sell	93,500 -92,800	-50%	-$7.4M	0.28%	115
2013 Q3	$12.5M	Buy	+186,300	New	+$12.8M	0.39%	105

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Clough Capital Partners's SLXP Position: Q1 2015 in Review

Clough Capital Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 47,900 shares — an estimated $5.51M sold.

Clough Capital Partners first reported a position in SLXP in Q3 2013 and held it in 6 quarters. The position peaked at $16.5M in Q2 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Clough Capital Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Clough Capital Partners sold 47,900 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $5.51M.
Clough Capital Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 6 quarters.
Clough Capital Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $16.5M in Q2 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Clough Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.